IBDEI1WH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31820,2)
 ;;=^5003672
 ;;^UTILITY(U,$J,358.3,31821,0)
 ;;=F79.^^138^1462^6
 ;;^UTILITY(U,$J,358.3,31821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31821,1,3,0)
 ;;=3^Intellectual Disabilities,Unspec
 ;;^UTILITY(U,$J,358.3,31821,1,4,0)
 ;;=4^F79.
 ;;^UTILITY(U,$J,358.3,31821,2)
 ;;=^5003673
 ;;^UTILITY(U,$J,358.3,31822,0)
 ;;=Z00.6^^138^1463^1
 ;;^UTILITY(U,$J,358.3,31822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31822,1,3,0)
 ;;=3^Exam of Participant of Control in Clinical Research Program
 ;;^UTILITY(U,$J,358.3,31822,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,31822,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,31823,0)
 ;;=F45.22^^138^1464^1
 ;;^UTILITY(U,$J,358.3,31823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31823,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,31823,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,31823,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,31824,0)
 ;;=F45.20^^138^1464^2
 ;;^UTILITY(U,$J,358.3,31824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31824,1,3,0)
 ;;=3^Hypochondiacal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,31824,1,4,0)
 ;;=4^F45.20
 ;;^UTILITY(U,$J,358.3,31824,2)
 ;;=^5003586
 ;;^UTILITY(U,$J,358.3,31825,0)
 ;;=F45.21^^138^1464^4
 ;;^UTILITY(U,$J,358.3,31825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31825,1,3,0)
 ;;=3^Hypochondriasis
 ;;^UTILITY(U,$J,358.3,31825,1,4,0)
 ;;=4^F45.21
 ;;^UTILITY(U,$J,358.3,31825,2)
 ;;=^5003587
 ;;^UTILITY(U,$J,358.3,31826,0)
 ;;=F45.29^^138^1464^3
 ;;^UTILITY(U,$J,358.3,31826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31826,1,3,0)
 ;;=3^Hypochondriacal Disorders NEC
 ;;^UTILITY(U,$J,358.3,31826,1,4,0)
 ;;=4^F45.29
 ;;^UTILITY(U,$J,358.3,31826,2)
 ;;=^5003589
 ;;^UTILITY(U,$J,358.3,31827,0)
 ;;=F45.8^^138^1464^9
 ;;^UTILITY(U,$J,358.3,31827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31827,1,3,0)
 ;;=3^Somatoform Disorders NEC
 ;;^UTILITY(U,$J,358.3,31827,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,31827,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,31828,0)
 ;;=F45.41^^138^1464^5
 ;;^UTILITY(U,$J,358.3,31828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31828,1,3,0)
 ;;=3^Pain Disorder Exclusively Related to Psychological Factors
 ;;^UTILITY(U,$J,358.3,31828,1,4,0)
 ;;=4^F45.41
 ;;^UTILITY(U,$J,358.3,31828,2)
 ;;=^5003590
 ;;^UTILITY(U,$J,358.3,31829,0)
 ;;=F45.42^^138^1464^6
 ;;^UTILITY(U,$J,358.3,31829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31829,1,3,0)
 ;;=3^Pain Disorder w/ Related Psychological Factors
 ;;^UTILITY(U,$J,358.3,31829,1,4,0)
 ;;=4^F45.42
 ;;^UTILITY(U,$J,358.3,31829,2)
 ;;=^5003591
 ;;^UTILITY(U,$J,358.3,31830,0)
 ;;=F45.0^^138^1464^7
 ;;^UTILITY(U,$J,358.3,31830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31830,1,3,0)
 ;;=3^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,31830,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,31830,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,31831,0)
 ;;=F45.9^^138^1464^8
 ;;^UTILITY(U,$J,358.3,31831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31831,1,3,0)
 ;;=3^Somatoform Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,31831,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,31831,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,31832,0)
 ;;=F45.1^^138^1464^10
 ;;^UTILITY(U,$J,358.3,31832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31832,1,3,0)
 ;;=3^Undifferntiated Somatoform Disorder
 ;;^UTILITY(U,$J,358.3,31832,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,31832,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,31833,0)
 ;;=99078^^139^1465^1^^^^1
 ;;^UTILITY(U,$J,358.3,31833,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31833,1,2,0)
 ;;=2^99078
 ;;^UTILITY(U,$J,358.3,31833,1,3,0)
 ;;=3^Group Health Education
